Home
CRO Services
CRO Services
Disease Models and Pharmacodynamics

Ophthalmic Disease

CNS Disease

Metabolic Disease

CVD and Other Disease

Regulatory Strategies and Safety Assessment

Regulatory Strategy

Drug Metabolism and Pharmacokinetics

Drug Safety Assessment

Safety Assessment of Medical Devices

Clinical Trials and
Laboratory Services

Clinical Trials

Laboratory Services

Technical platform and instrument Bioanalysis Biomarker Clinical and Molecular Pathology Laboratory

TriApex Vision
Innovative CRO enabling new drug R&D in disease-oriented fields
Disease-Oriented R&D
Disease-Oriented R&D
Ophthalmology

In vivo Ocular Disease Models

Ocular Routes of Administration

Clinical Ophthalmology Examinations

Bioanalysis of Eye Tissues

Ophthalmology Pathology Evaluation

Clinical Service

CNS

Disease Models

Drug Safety Assessment

Clinical Research Services

Project Experience

Metabolic Disease

Disease Models

Service Capacity

Clinical Research Services

Project Experience

Innovation

iPSCs & Organoids Evaluation Department

Cell Biology & Immunology Evaluation Department

TriApex Empowered
To build an international drug evaluation platform for ophthalmic /CNS/ metabolic disease
News&Insight
News&Insight
Top NewsLatest Industry NewsThoughts and InsightsImportant EventsVideo ClassDocument / ManualQ&A
TriApex Vision
Witness the development of industry innovation, share TriApex exclusive insights
Investor
Investor
AnnouncementCorporate GovernancePromotional MaterialsInvestor Contact
TriApex Vision
Building a CRO "bioeconomy" industry ecosystem that meets international standards and is domestically first-class
About us
About us
TriApex ProfileCredibility QualificationSocial ResponsibilityJoin us
鼎泰愿景
Dedicated to scientific assessment, enabling transformation of innovation, and improving quality of life
Global
En Cn
×
Location： Home Disease-Oriented R&D Ophthalmology In vivo Ocular Disease Models
Induced Corneal Neovascularization

Introduction

The corneal neovascularization can be induced in various animals by corneal suture or chemicals. This model can be used early model for efficacy test of anti-neovascularization drugs.

Disease-Oriented R&D
Ophthalmology
In vivo Ocular Disease Models
Ocular Routes of Administration
Clinical Ophthalmology Examinations
Bioanalysis of Eye Tissues
Ophthalmology Pathology Evaluation
Clinical Service
CNS
Disease Models
Drug Safety Assessment
Clinical Research Services
Project Experience
Metabolic Disease
Disease Models
Service Capacity
Clinical Research Services
Project Experience
Innovation
iPSCs & Organoids Evaluation Department
Cell Biology & Immunology Evaluation Department
An innovative CRO dedicated to providing disease-oriented one-stop solutions to enable the R&D for global pharmaceutical enterprises and research institutions.
CRO Services

Disease Models and Pharmacodynamics

Regulatory Strategies and Safety Assessment

Clinical Trials and Laboratory Services

Disease-Oriented R&D

Ophthalmology

CNS

Metabolic Disease

Innovation

News&Insight

Top News

Latest Industry News

Thoughts and Insights

Important Events

Video Class

Document / Manual

Q&A

About us

TriApex Profile

Credibility Qualification

Social Responsibility

Join us

Tel：+86 (025) 5819-6588

Email：BD@tri-apex.com

Address：No. 9 Xinglong Road, Jiangbei New Area, Nanjing, China

Members of TriApex
TriApex Nanjing
TriApex Nanjing Kunming Biomed (KBI) TriApex Med TriApex Biotechnology Harborside
Official WeChat account
Official video account
Copyright©TriApex Laboratories Co., Ltd.   苏ICP备18053553号-3   苏公网安备32011202001081